Momentum Biotechnologies is a drug discovery partner providing specialized mass spectrometry technologies to biopharmaceutical clients across the globe. Momentum helps clients identify, validate, and characterize therapeutic leads through a diverse portfolio of services, including affinity selection mass spectrometry (ASMS), covalent binding assays, proteomics / chemoproteomics, small-molecule analysis, and data products.
Our core team has worked together for over twenty years, developing a keen understanding of client needs and establishing Momentum as one of the largest high-throughput mass spectrometry labs in the world. Thanks to a combination of proven workflows, state-of-the-art facilities, and extensive scientific experience, Momentum is uniquely positioned to deliver rapid, reliable answers to a wide range of pressing research questions. In addition to our original laboratory, based in Billerica, Massachusetts, we have expanded to a second site in Freising, Germany.